Page 210 - Neuropsychiatric.indd
P. 210

healthcare professionals from the American Heart Association/American Stroke Association.   64. Lovell AR, Ernst ME. Drug-induced hypertension: Focus on mechanisms and management.
 Stroke. 2015;46(7):2032-60.   Curr Hypertens Rep. 2017;19(5):39.

 50. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a   65. Grossman E, Messerli FH. Drug-induced hypertension: an unappreciated cause of secondary
 simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32(4):891-7.   hypertension. Am J Med. 2012;125(1):14-22.
 51. Teasdale G, Maas A, Lecky F, Manley G, Stocchetti N, Murray G. The Glasgow Coma Scale   66. Zhong Z, Wang L, Wen X, Liu Y, Fan Y, Liu Z. A meta-analysis of effects of selective
 at 40 years: standing the test of time. Lancet Neurol. 2014;13(8):844-54.    serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from

 52. Yee J, Kaide CG. Emergency Reversal of Anticoagulation. West J Emerg Med. 2019;20(5):770-  placebo and serotonin and noradrenaline reuptake inhibitor controlled trials.
 83.               Neuropsychiatr Dis Treat. 2017;13:2781-96.
 53. James RF, Palys V, Lomboy JR, Lamm JR Jr, Simon SD. The role of anticoagulants,   67. Zhao T, Wang X, Xu T, Xu X, Liu Z. Bevacizumab significantly increases the risks of

 antiplatelet agents, and their reversal strategies in the management of intracerebral   hypertension and proteinuria in cancer patients: A systematic review and comprehensive
 hemorrhage. Neurosurg Focus. 2013;34(5):E6.   meta-analysis. Oncotarget. 2017;8(31):51492-506.
 54. Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, et al. Treatment and   68. Robert N, Wong GW, Wright JM. Effect of cyclosporine on blood pressure. Cochrane
 prevention of heparin-induced thrombocytopenia: antithrombotic therapy and   Database Syst Rev. 2010;(1):CD007893.
 prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based   69. Aw TJ, Haas SJ, Liew D, Krum H. Meta-analysis of cyclooxygenase-2 inhibitors and their

 Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e495S-e530S.   effects on blood pressure. Arch Intern Med. 2005;165(5):490-6.
 55. Morelli N, Rota E, Iafelice I, Pierfranceschi M, Donata G. Acute treatment of thrombolysis-  70. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-
 associated symptomatic intracranial hemorrhage: a case report. Int J Sci. 2014;3(1):1-3.   inflammatory drugs on blood pressure. Arch Intern Med. 1993;153(4):477-84.

 56. Patel MK, Chhabra SK Pfeiffer M. Man with spontaneous intracranial hemorrhage on   71. de Jesus-Gonzalez N, Robinson E, Moslehi J, Humphreys BD. Management of antiangiogenic
 therapeutic enoxaparin, clopidogrel, and aspirin. The Medicine Forum. 2007;9(8):14-7.    therapy-induced hypertension. Hypertension. 2012;60(3):607-15.
 57. ศูนย์โรคหลอดเลือดสมองศิริราช. National Institute of Health Stroke Scale, Thai version   72. Kıvrak Y, Güvenç TS, Akbulut N, Yağcı I, Cığşar G, Gündüz S, et al. Accelerated hypertension
 (NIHSS-T). [accessed 2 February 2021]. Available from:  https://www.si.mahidol.ac.th/   after venlafaxine usage. Case Rep Psychiatry. 2014:659715.

 center/sirirajstrokecenter/TH/StrokeContent/content/doctor/Stroke_Scale.aspx   73. Saljoughian M. Hypotension: A clinical care review. US Pharm. 2014:39(2):2-4.
 58. National Institutes of Health (National Institute of Neurological Disorders and Stroke). NIH   74. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure,
 Stroke Scale. [accessed 2 February 2021]. Available from: https://www.stroke.nih.gov/   and multiple system atrophy. The Consensus Committee of the American Autonomic
 resources/scale.htm   Society and the American Academy of Neurology. Neurology. 1996;46(5):1470.

 59. สมาคมความดันโลหิตสูงแห่งประเทศไทย. แนวทางการรักษาโรคความดันโลหิตสูงในเวชปฏิบัติทั่วไป พ.ศ.  75. Trinkley KE, Page RL. Chapter 28 Hypotension In: Tisdale JE et al., eds. Drug-Induced
 2562. เชียงใหม่: บริษัท ทริค ธิงค์, 2562.   Diseases: Prevention, Detection, and Management. 3rd ed. United States: American Society
 60. MacLaughlin EJ, Saseen JJ. Chapter 30 Hypertension. In: Dipiro JT et al., eds.   of Health-System Pharmacists, Inc., 2018.
 Pharmacotherapy: A pathophysiologic approach. 11th ed. United States: McGraw Hill   76. Rivasi G, Rafanelli M, Mossello E, Brignole M, Ungar A. Drug-related orthostatic hypotension:

 Companies, Inc, 2020.   beyond anti-hypertensive medications. Drugs Aging. 2020;37(10):725-38.
 61. Claus LW, Saseen JJ. Chapter 27 Hypertension In: Tisdale JE et al., eds. Drug-Induced   77. Verhaeverbeke I, Mets T. Drug-induced orthostatic hypotension in the elderly: avoiding its
 Diseases: Prevention, Detection, and Management. 3rd ed. United States: American   onset. Drug Saf. 1997;17(2):105-18.
 Society of Health-System Pharmacists, Inc., 2018.   78. Carvedilol. Monograph for professional. [accessed 29 November 2020]. Available from:

 62. Foy MC, Vaishnav J, Sperati CJ. Drug-Induced hypertension. Endocrinol Metab Clin North   https://www.drugs.com/monograph/carvedilol.html
 Am. 2019;48(4):859-73.    79. Quetiapine. Monograph for professional. [accessed 29 November 2020]. Available from:
 63. Masi S, Uliana M, Gesi M, Taddei S, Virdis A. Drug-induced hypertension: Know the problem   https://www.drugs.com/monograph/quetiapine.html#dosage
 to know how to deal with it. Vascul Pharmacol. 2019;115:84-88.    80. Trazodone. Monograph for professional. [accessed 29 November 2020]. Available from:

                   https://www.drugs.com/monograph/trazodone.html


 188                                                                                                   189
                                                                                                       189
   205   206   207   208   209   210   211   212   213   214   215